MCID: CHL039
MIFTS: 32

Choledocholithiasis malady

Category: Gastrointestinal diseases

Aliases & Classifications for Choledocholithiasis

About this section

Aliases & Descriptions for Choledocholithiasis:

Name: Choledocholithiasis 11 13 48 37 66

Classifications:



External Ids:

Disease Ontology11 DOID:11755
MeSH37 D042883

Summaries for Choledocholithiasis

About this section
MalaCards based summary: Choledocholithiasis is related to ascending cholangitis and biliary dyskinesia. An important gene associated with Choledocholithiasis is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways are FOXA2 and FOXA3 transcription factor networks and Lysosome. Affiliated tissues include liver, testes and heart.

Related Diseases for Choledocholithiasis

About this section

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 102)
idRelated DiseaseScoreTop Affiliating Genes
1ascending cholangitis30.0ABCB4, ALB
2biliary dyskinesia29.4CTSC, SOBP
3extrahepatic cholestasis29.2ALB, ALPP, F2, GPT
4hepatocellular carcinoma28.9ABCB4, ALB, F2, GPT
5paraneoplastic pemphigus10.6F2, GPT
6patent foramen ovale10.6ABCB4, GPT
7wernicke encephalopathy10.5ALB, UGT1A1
8hereditary antithrombin deficiency type i10.5ALB, F2
9urinary bladder posterior wall cancer10.5ALB, GPT
10marek disease10.5ALB, F2
11pontocerebellar hypoplasia10.5ABCB4, UGT1A1
12oral cavity carcinoma in situ10.5ALB, F2
13spastic paraplegia 3a10.5F2, UGT1A1
14acute kidney tubular necrosis10.5ALB, F2
15parathyroid gland disease10.5ALB, F2
16oral erosive lichen10.5GPT, SLC17A5
17splenic infarction10.4ALB, F2
18degenerative myopia10.4ALB, F2
19pericholangitis10.4ALB, F2
20anterior foramen magnum meningioma10.4ALB, F2
21acute liver failure10.4ALB, F2
22cholelithiasis10.4
23nondystrophic myotonia10.4GPT, SLC17A5
24dermatitis10.4ALB, F2
25ovarian cystic teratoma10.4ALB, F2
26lip carcinoma in situ10.4ALB, F2
27cat-scratch disease10.4GPT, SLC17A5
28hypohidrosis10.4ABCB4, CTSC
29ischemic heart disease10.4ALB, F2
30alopecia10.4ALB, F2
31cutaneous porphyria10.3ALB, F2
32fraxf syndrome10.3ALPP, GPT
33neurogenic bowel10.3ALB, F2
34cholangitis10.3
35amelogenesis imperfecta10.3ALB, F2
36dentinogenesis imperfecta10.3ALB, F2
37bubonic plague10.3ALB, F2
38oculocerebrorenal syndrome10.3ALB, SLC17A5
39bartter disease10.3ALB, F2
40ulcerative blepharitis10.2ALB, F2
41dermatomyositis10.2ABCB4, ALB, UGT1A1
42fibrous histiocytoma10.2ALB, F2, GPT
43pancreatitis10.2
44angina pectoris10.2ALB, F2
45eczematous dermatitis of eyelid10.2ALB, F2, GPT
46pyeloureteritis cystica10.2ALB, F2, UGT1A1
47spinocerebellar ataxia 810.2ALB, F2, GPT
48autoimmune disease of cardiovascular system10.2ABCB4, ALB, F2
49fallopian tube carcinoma10.2ABCB4, ALB, F2
50mixed mineral dust pneumoconiosis10.2ALB, F2

Graphical network of the top 20 diseases related to Choledocholithiasis:



Diseases related to choledocholithiasis

Symptoms for Choledocholithiasis

About this section

Drugs & Therapeutics for Choledocholithiasis

About this section

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
EtomidatePhase 46233125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
2
MidazolamPhase 466159467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
3
Ursodeoxycholic acidPhase 483128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
4
MeperidinePhase 46857-42-14058
Synonyms:
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]
1-Methyl-4-phenylisonipecotic acid, ethyl ester
1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
4-Carbethoxy-1-methyl-4-phenylpiperidine
4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
50-13-5 (hydrochloride)
57-42-1
610593_ALDRICH
610593_FLUKA
AC1L1HBJ
C07128
CHEBI:122528
CHEMBL607
CID4058
D008614
D08343
DB00454
DEA No. 9230
Demarol
Demerol
DivK1c_000983
Dolcontral
Dolosal
Dolsin
EINECS 200-329-1
Ethyl 1-methyl-4-phenylisonipecotate
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
HSDB 3116
IDI1_000983
Isonipecain
Isonipecaine
Isonipecaïne
Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester
KBio1_000983
 
L000908
LS-85121
Lidol
Lydol
Meperidine
Meperidine solution
Meperidol
Methyl phenylpiperidine carbonic acid ethyl ester
MolPort-001-785-564
N-Methyl-4-phenyl-4-carbethoxypiperidine
NINDS_000983
Nemerol
Operidine EPJ I
Operidine EPJ-I
Pethanol
Pethidin
Pethidine
Pethidine (INN)
Pethidine DBL
Pethidine DBL (TN)
Pethidine dbl
Pethidineter
Pethidinum
Pethidinum [INN-Latin]
Petidina
Petidina [INN-Spanish]
Petydyna
Petydyna [Polish]
Phetidine
Piperosal
Pipersal
Péthidine
Sauteralgyl
Spasmedal
Spasmodolin
UNII-9E338QE28F
YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
meperidine
5Chlorhexidine gluconate448
6
Chlorhexidine44855-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
7glucagon441
8Scopolamine hydrobromide64114-49-8

Interventional clinical trials:

(show all 37)
idNameStatusNCT IDPhase
1Etomidate vs. Midazolam for Sedation During ERCPCompletedNCT02027311Phase 4
2UDCA for Symptomatic Gallstone DiseaseCompletedNCT00161083Phase 4
3Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the PapillaRecruitingNCT02703077Phase 4
4Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD StonesCompletedNCT02592811Phase 3
5Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary ObstructionTerminatedNCT01424657Phase 3
6Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBDCompletedNCT01673269
7Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely CholedocholithiasisCompletedNCT00807729
8Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP CholangitisCompletedNCT02594891
9Left Lateral Position and Prone Position for Endoscopic Retrograde CholangiopancreatographyCompletedNCT02594475
10Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic CholecystectomyCompletedNCT02037958
11Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845
12Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic CholecystectomyCompletedNCT01824186
13Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall StonesCompletedNCT01683240
14Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted StoneCompletedNCT00173368
15Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct StonesCompletedNCT01046552
16Early EUS in Acute Biliary PancreatitisCompletedNCT02430285
17Routine Bile Collection for Microbiological Analysis During CholangiographyCompletedNCT01003782
18Cytological Evaluation of Biliary Epithelium After Endoscopic SphincterotomyCompletedNCT01135732
19Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
20Comparison of LCBDE vs ERCP + LC for CholedocholithiasisRecruitingNCT02515474
21Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/CholedocholithiasisRecruitingNCT00416234
22Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCPRecruitingNCT02611453
23Laser Versus Mechanical Lithotripsy of Bile Duct StonesRecruitingNCT01759979
24A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon DilatationRecruitingNCT00451581
25EUS Guided ERCP in Bile Duct Stone RemovalRecruitingNCT02870686
26Optimization and Cost-effective Analysis of Secondary Biliary Stones' ManagementsRecruitingNCT02554097
27Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
28Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde CholangiopancreatogrRecruitingNCT01414400
29Los Angeles Prospective GI Biliary and EUS SeriesRecruitingNCT02196935
30Prospective Validation of "Cholecystectomy First" Strategy for Gallstone MigrationActive, not recruitingNCT02461147
31Comparison of Papillary Balloon Dilatation Vs.Sphincterotomy for Lithotripsy in Difficult Sphincterotomy or Distal CBD TaperingActive, not recruitingNCT00329888
32Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary PancreatitisActive, not recruitingNCT01687959Phase 0
33The Clinical Characteristics of the Patients With Choledocholithiasis Without CholangitisEnrolling by invitationNCT02647593
34Direct Peroral Cholangioscopy by Using an Ultra-slim Upper EndoscopeEnrolling by invitationNCT02276157
35Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk PatientsTerminatedNCT00612846
36Management of Common Bile Duct (CBD) Stones at Laparoscopic CholecystectomyTerminatedNCT00124033
37Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone ClearanceWithdrawnNCT01475864

Search NIH Clinical Center for Choledocholithiasis


Cochrane evidence based reviews: choledocholithiasis

Genetic Tests for Choledocholithiasis

About this section

Anatomical Context for Choledocholithiasis

About this section

MalaCards organs/tissues related to Choledocholithiasis:

34
Liver, Testes, Heart

Animal Models for Choledocholithiasis or affiliated genes

About this section

Publications for Choledocholithiasis

About this section

Articles related to Choledocholithiasis:

(show top 50)    (show all 596)
idTitleAuthorsYear
1
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography in suspected choledocholithiasis: A systematic review. (27080611)
2016
2
Accuracy of scoring systems for suspected choledocholithiasis: A 5-variable score system versus ASGE clinical guidelines. (27089986)
2016
3
Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013. (27556900)
2016
4
Accuracy of ASGE criteria for the prediction of choledocholithiasis. (27063334)
2016
5
Comparison Between Endoscopic Biliary Stenting and Nasobiliary Drainage in Patients with Acute Cholangitis due to Choledocholithiasis: Is Endoscopic Biliary Stenting Useful? (26897928)
2015
6
Detectability of choledocholithiasis on CT: The effect of positive intraduodenal enteric contrast on portovenous contrast-enhanced studies. (26458858)
2015
7
Learning curve and outcome of laparoscopic transcystic common bile duct exploration for choledocholithiasis. (26395452)
2015
8
Management of Suspected Choledocholithiasis: A Decision Analysis for Choosing the Optimal Imaging Modality. (26399621)
2015
9
'Single-Sitting' Laparoscopic Cholecystectomy and Endoscopic Removal of Common Bile Duct Stone for Cholelithiasis and Choledocholithiasis: a Feasibility Study. (26730094)
2015
10
Endoscopic Sphincterotomy Using the Rendezvous Technique for Choledocholithiasis during Laparoscopic Cholecystectomy: A Case Report. (25298761)
2014
11
Successful single-session endosonography-based endoscopic retrograde cholangiopancreatography without fluoroscopy in pregnant patients with suspected choledocholithiasis: a case series. (23798477)
2013
12
Endoscopic papillary balloon dilation for a 7-year-old girl with choledocholithiasis. (23679173)
2013
13
Risk factors of choledocholithiasis formation after liver transplantation. (23558078)
2013
14
Relationship of CA 19-9 with choledocholithiasis and cholangitis. (21796554)
2011
15
Endoscopic papillary balloon dilation for removal of choledocholithiasis: indications, advantages, complications, and long-term follow-up results. (21461066)
2011
16
Laparoscopic exploration of the common bile duct with a rigid scope in patients with problematic choledocholithiasis. (20354699)
2010
17
Selective use of magnetic resonance cholangiopancreatography in clinical practice may miss choledocholithiasis in gallstone pancreatitis. (21092433)
2010
18
Preoperative diagnosis of choledocholithiasis: the role of MRCP. (19516211)
2009
19
Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis. (19210291)
2009
20
Management of choledocholithiasis in patients undergoing cholecystectomy. (19566539)
2009
21
Patients with a high probability of choledocholithiasis are best managed with ERCP without EUS. (19327495)
2009
22
Laparoendoscopic "rendezvous" versus laparoscopic antegrade sphincterotomy for choledocholithiasis. (18707043)
2008
23
Balloon sphincteroplasty in the management of choledocholithiasis in a 10-week-old infant. (18287994)
2008
24
Common bile duct thrombi secondary to hepatoma, with biliary invasion mimicking a choledocholithiasis (with video). (17258996)
2007
25
Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio-pancreatography? A systematic review. (18049172)
2007
26
Laparoscopic management of difficult recurrent choledocholithiasis. (17651582)
2007
27
Optimizing choledocholithiasis management: a cost-effectiveness analysis. (17224499)
2007
28
Conversion rate for laparoscopic cholecystectomy after endoscopic retrograde cholangiography in the treatment of choledocholithiasis: does the time interval matter? (17031740)
2006
29
EUS vs MRCP for detection of choledocholithiasis. (16860077)
2006
30
Echo-endoscopy versus endoscopic retrograde cholangiography for the diagnosis of choledocholithiasis: the influence of the size of the stone and diameter of the common bile duct. (16444379)
2005
31
Accuracy of computed tomographic intravenous cholangiography (CT-IVC) with iotroxate in the detection of choledocholithiasis. (15627178)
2005
32
Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis. (12618941)
2003
33
Cholelithiasis and choledocholithiasis after sequential cytarabine and asparaginase. (12902918)
2003
34
Endoscopic management of choledocholithiasis resulting from a biliary metal stent. (12822110)
2003
35
Treatment of choledocholithiasis in pregnancy: a case report. (12592428)
2003
36
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. (12603536)
2003
37
Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis. (12811312)
2003
38
Recurrence of biliary symptoms after endoscopic sphincterectomy for choledocholithiasis in patients with gallbladder stones. (11911095)
2002
39
Choledocholithiasis in the Setting of Portal Hypertension. (11469971)
2001
40
Successful endoscopic sphincterotomy using a papillotome tipped with a balloon for cases of choledocholithiasis complicated by duodenal diverticula. (11721786)
2001
41
Long-term stenting for choledocholithiasis. (10946479)
2000
42
Management of choledocholithiasis during pregnancy by magnetic resonance cholangiography and laparoscopic common bile duct stone extraction. (11083218)
2000
43
Eight years' experience with the use of a transcystic common bile duct duodenal double-lumen catheter for the treatment of choledocholithiasis. (9780991)
1998
44
Assessment of indicators for predicting choledocholithiasis before laparoscopic cholecystectomy. (17344723)
1998
45
Laparo-endoscopic "rendezvous": a new technique in the choledocholithiasis treatment. (9840078)
1998
46
Choledocholithiasis and gallstone pancreatitis. (9512804)
1997
47
Biliary stents as temporary treatment for choledocholithiasis in pregnant patients. (9260726)
1997
48
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. (8677945)
1996
49
Laparoscopic treatment of known choledocholithiasis. (8658332)
1996
50
Left lateral laparoscopic cholecystectomy and its relevance to choledocholithiasis. (8363482)
1993

Variations for Choledocholithiasis

About this section

Expression for genes affiliated with Choledocholithiasis

About this section
Search GEO for disease gene expression data for Choledocholithiasis.

Pathways for genes affiliated with Choledocholithiasis

About this section

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7ALB, F2
29.0CTSC, GUSB, SLC17A5

GO Terms for genes affiliated with Choledocholithiasis

About this section

Cellular components related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lysosomeGO:00057649.0CTSC, GUSB, SLC17A5
2extracellular spaceGO:00056158.4ALB, CTSC, F2, GPT, GUSB

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1acute-phase responseGO:00069539.8F2, UGT1A1
2response to organic substanceGO:00100339.2ALB, CTSC, UGT1A1

Molecular functions related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1pyridoxal phosphate bindingGO:00301709.8ALB, GPT

Sources for Choledocholithiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet